Scientific Committee

Antonia Morey Matamalas, Charles River Laboratories, UK
Barbara Lenz, Roche, Switzerland
Cécile Sobry, Labo-Novaxia, France
Charlotte Dalsgaard, Novonordisk, Denmark
Dirk Schaudien, Fraunhofer ITEM, Germany
Emily Meseck, Novartis, USA
Fabienne Lien, Royal Veterinary College, UK
Frederic Schorsch, Bayer, France
Heike Marxfeld, Basf, Germany
Jacqui Stewart, Labcorp, UK
Laetitia Elies, Charles River Laboratories, France
Maike Huisinga, Basf, Germany
Matthew Jacobsen, AstraZeneca, UK
Sandra De Jonghe, Johnson&Johnson, Belgium
Sébastien Laurent, Sanofi, France
Shelley Patrick, Alnylam, USA
Xavier Palazzi, AstraZeneca, USA